Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
23 January 2019 | Story Charlene Stanley | Photo Charlene Stanley
Michele Middle
Michelle Middle, CMO of Farmovs, looks forward to expanding their operations after the UFS acquired 100% shareholding in 2018.

In medical research, there are NO shortcuts.

The journey of a new medicine from lab to pharmacy shelf takes on average at least 10 years.

Michelle Middle’s journey from young medical graduate starting her first job at FARMOVS to becoming the company’s Chief Medical Officer, was more than twice that long. It was a journey that systematically and adequately equipped her to now Co-captain this flagship enterprise through its biggest challenge yet.

Michelle remembers how Farmovs started in 1974 as a research centre in the Department of Pharmacology. After graduating as medical doctor, she joined Farmovs in 1993, shortly before they moved to their current extensive facilities just south of the Sasol Library.

In 2000, international Clinical Research Organization (CRO) giant Parexel acquired a 70% shareholding, and the name changed to Farmovs-Parexel.

“Parexel really invested a lot in infrastructure and technology, bringing facilities here on par with the best in the world,” says Michelle.

Her own journey in medical research took her to George and later to the US and UK, where she held various international executive leadership positions in international companies.

When the UFS acquired a 100% shareholding in Farmovs earlier this year, she came full circle, as she returned to Bloemfontein to spearhead the expansion of patient studies in collaboration with the Faculty of Health Sciences.

“The opportunities we have here are really enormous,” says an excited Michelle.

“We are the only university in the country with this kind of infrastructure. Apart from our state-of-the-art bioanalytical lab, we also have facilities to accommodate close to 100 research participants. We now have 45 years’ experience in advanced medical research, plus established international clients. We can provide pharmaceutical companies with basically everything they need to develop new medicines.”

Another exciting development is that they are expanding their clinical-trial patient population next year from healthy individuals to people suffering from a host of chronic conditions.

“While they are part of our clinical trials, patients gain valuable insight in their own conditions. We also sometimes pick up underlying medical issues they were not even aware of,” says Michelle.

The 150 Farmovs staff members range from doctors and nurses, to technologists, medical writers, and managers. While not technically part of the university staff, they form a valued part of the Bloemfontein Campus community.

News Archive

Bok jersey – Oupa’s next goal
2014-05-22

Former Shimla captain and 2013 Varsity Cup player that Rocks, Teboho Oupa Mohoje, was recently added to the 36-man Springbok training squad for the coming 2014 mid-year international tests.

Teboho already achieved his goal for 2014 when he earned himself Super Rugby caps with the Cheetahs. Next, he has set his sights on becoming a regular with the Boks.

“I found out a week before the announcement was made,” says Oupa. “When [Cheetahs] coach Naka [Drotske] told me, I was actually shocked and had no reaction. I even asked him if he was serious. But it all started to sink in when the announcement was made public.”

This star on the rise is actually better known as Oupa – as he was dubbed by his primary school coach who noticed he had grey hair. Oupa used to study BAgric and now studies Human Movement Sciences at Kovsies, although he does not play Varsity rugby anymore.

“I’ve learnt a lot. I made good mates like Willie Britz [now playing for the Lions] and Freddie Ngoza. I have a lot of great memories and all-in-all it was a good learning curve,” he fondly sums up his time as a Varsity rugby player.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept